Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...

Pfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior day's close.

Okay, well, I have not been recommending, my stock in the pharma business is Lilly, and the med equipment is Abbott. I do ...

This was the stock's second consecutive day of losses.

A federal court dismissed a journalist’s claims against Pfizer executives and a member of the former Biden Administration for ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.